David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Home BancShares
HOMB
$5.98B
| $315K | ﹤0.01% |
+18,570
| New | +$294K |
|
3252
Xcel Energy
XEL
$48.2B
| $315K | ﹤0.01% |
9,056
-47,327
| -84% | -$1.69M |
|
|
KBAL
3253
DELISTED
Kimball International
KBAL
| $315K | ﹤0.01% |
30,096
+12,822
| +74% | +$122K |
|
3254
Scansource
SCSC
$1.14B
| $314K | ﹤0.01% |
7,730
-7,814
| -50% | -$296K |
|
|
ADNC
3255
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
| $314K | ﹤0.01% |
69,237
+44,847
| +184% | +$204K |
|
3256
Stoneridge
SRI
$205M
| $312K | ﹤0.01% |
27,667
+12,697
| +85% | +$153K |
|
|
GOLD
3257
DELISTED
Randgold Resources Ltd
GOLD
| $312K | ﹤0.01% |
+4,530
| New | +$340K |
|
3258
Huntington Bancshares
HBAN
$34.2B
| $310K | ﹤0.01% |
+28,075
| New | +$296K |
|
|
ARRY
3259
DELISTED
Array Biopharma Inc
ARRY
| $308K | ﹤0.01% |
41,750
-313,319
| -88% | -$2.23M |
|
|
SCNB
3260
DELISTED
Suffolk Bancorp
SCNB
| $308K | ﹤0.01% |
12,953
+2,297
| +22% | +$52K |
|
|
NFBK
3261
DELISTED
Northfield Bancorp
NFBK
| $306K | ﹤0.01% |
+20,655
| New | +$300K |
|
|
CLD
3262
PUT
DELISTED
Cloud Peak Energy Inc
CLD
| $306K | ﹤0.01% |
52,500
-40,000
| -43% | -$295K |
|
3263
Lincoln National
LNC
$8.16B
| $305K | ﹤0.01% |
5,315
-39,041
| -88% | -$2.18M |
|
|
CRR
3264
CALL
DELISTED
Carbo Ceramics Inc.
CRR
| $305K | ﹤0.01% |
10,000
-58,700
| -85% | -$2.06M |
|
3265
ASML
ASML
$670B
| $304K | ﹤0.01% |
3,005
-11,178
| -79% | -$1.17M |
|
|
NAV
3266
DELISTED
Navistar International
NAV
| $304K | ﹤0.01% |
10,322
-57,638
| -85% | -$1.73M |
|
|
CRC
3267
PUT
DELISTED
California Resources Corporation
CRC
| $304K | ﹤0.01% |
4,000
-11,872
| -75% | -$726K |
|
|
NBIS
3268
CALL
Nebius Group N.V.
NBIS
$60.3B
| $303K | ﹤0.01% |
20,000
-134,700
| -87% | -$2.17M |
|
3269
Materion
MTRN
$4.84B
| $302K | ﹤0.01% |
7,867
-20,910
| -73% | -$751K |
|
3270
Waters Corp
WAT
$40.7B
| $302K | ﹤0.01% |
2,433
-79,456
| -97% | -$9.48M |
|
|
PRAH
3271
DELISTED
PRA Health Sciences, Inc.
PRAH
| $302K | ﹤0.01% |
+10,462
| New | +$292K |
|
3272
Middlesex Water
MSEX
$1.11B
| $301K | ﹤0.01% |
+13,210
| New | +$295K |
|
|
DANG
3273
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $301K | ﹤0.01% |
31,566
-24,927
| -44% | -$219K |
|
3274
Winmark
WINA
$1.25B
| $300K | ﹤0.01% |
3,425
+683
| +25% | +$56K |
|
|
TTPH
3275
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $300K | ﹤0.01% |
+410
| New | +$308K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.